NKTR

0.676

3.57% -0.025

Dopo l'orario di chiusura: .68 0.004 +0.59%

Nektar Therapeutics (NKTR)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario

Precedente Chiudi:

$0.701

Aprire:

$0.71

Volume 24 ore:

3.36M

Relative Volume:

1.83

Capitalizzazione di mercato:

$123.99M

Reddito:

$90.12M

Utile/perdita netta:

$-276.06M

Rapporto P/E:

-0.463

EPS:

-1.46

Flusso di cassa netto:

$-193.47M

1 W Prestazione:

-18.29%

1M Prestazione:

-43.19%

6M Prestazione:

-42.71%

1 anno Prestazione:

+0.90%

Intervallo 1D:

$0.6618

$0.72

Intervallo di 1 settimana:

$0.6618

$0.8565

Portata 52W:

$0.6303

$1.928

Nektar Therapeutics Stock (NKTR) Company Profile

Nome

Nektar Therapeutics

Settore

Healthcare (1183)

Industria

Biotechnology (679)

Telefono

(415) 482-5300

Indirizzo

455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA

Dipendente

137

Cinguettio

@nektarnews

Prossima data di guadagno

2024-11-07

Ultimi documenti SEC

NKTR's Discussions on Twitter

Confronta NKTR con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
NKTR Nektar Therapeutics	0.676	123.99M	90.12M	-276.06M	-193.47M	-1.46
VRTX Vertex Pharmaceuticals Inc	469.32	122.13B	10.63B	-479.80M	-1.35B	-1.99
REGN Regeneron Pharmaceuticals Inc	710.00	78.30B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	646.64	39.73B	1.86B	-40.29M	-1.28B	-0.85
ALNY Alnylam Pharmaceuticals Inc	276.19	35.50B	2.09B	-332.26M	16.06M	-2.62
BNTX Biontech Se Adr	117.61	28.47B	3.30B	-501.07M	1.03B	-2.1146

Nektar Therapeutics Stock (NKTR) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-01-08	Iniziato	B. Riley Securities	Buy
2024-12-10	Iniziato	H.C. Wainwright	Buy
2024-11-04	Iniziato	Piper Sandler	Overweight
2024-09-30	Ripresa	BTIG Research	Buy
2024-06-28	Iniziato	Rodman & Renshaw	Buy
2023-11-20	Ripresa	JP Morgan	Underweight
2023-11-09	Aggiornamento	TD Cowen	Market Perform → Outperform
2023-05-10	Aggiornamento	Jefferies	Underperform → Hold
2023-02-24	Downgrade	Jefferies	Hold → Underperform
2022-08-08	Downgrade	JP Morgan	Neutral → Underweight
2022-05-31	Ripresa	Jefferies	Hold
2022-04-18	Downgrade	Goldman	Neutral → Sell
2022-03-15	Downgrade	Cowen	Outperform → Market Perform
2022-03-15	Downgrade	Mizuho	Buy → Neutral
2022-03-14	Downgrade	BTIG Research	Buy → Neutral
2022-03-14	Downgrade	BofA Securities	Neutral → Underperform
2022-03-14	Downgrade	Stifel	Buy → Hold
2022-03-14	Downgrade	William Blair	Outperform → Mkt Perform
2022-03-09	Aggiornamento	Oppenheimer	Perform → Outperform
2021-11-08	Aggiornamento	The Benchmark Company	Hold → Buy
2021-09-10	Iniziato	BofA Securities	Neutral
2021-06-28	Aggiornamento	Stifel	Hold → Buy
2021-05-18	Ripresa	Goldman	Neutral
2021-02-22	Downgrade	The Benchmark Company	Buy → Hold
2021-01-06	Iniziato	Stifel	Hold
2020-09-14	Iniziato	JP Morgan	Neutral
2020-06-10	Downgrade	CFRA	Hold → Sell
2020-05-12	Reiterato	H.C. Wainwright	Neutral
2020-04-22	Iniziato	The Benchmark Company	Buy
2020-03-30	Aggiornamento	Goldman	Sell → Neutral
2020-03-04	Iniziato	Barclays	Overweight
2020-02-03	Aggiornamento	Mizuho	Neutral → Buy
2019-10-24	Iniziato	Oppenheimer	Perform
2019-10-08	Downgrade	Goldman	Buy → Sell
2019-08-09	Downgrade	JP Morgan	Overweight → Neutral
2019-08-09	Downgrade	Jefferies	Buy → Hold
2019-08-09	Downgrade	Mizuho	Buy → Neutral
2019-03-15	Iniziato	SVB Leerink	Mkt Perform
2018-12-13	Iniziato	Goldman	Buy
2018-06-11	Downgrade	H.C. Wainwright	Buy → Neutral
2018-06-04	Reiterato	H.C. Wainwright	Buy
2018-04-20	Iniziato	Seaport Global Securities	Buy
2018-04-13	Ripresa	Piper Jaffray	Overweight
2018-04-06	Reiterato	Mizuho	Buy
2018-04-02	Ripresa	H.C. Wainwright	Buy

Mostra tutto

Nektar Therapeutics Borsa (NKTR) Ultime notizie

04:37 AM